Aminopyrine breath test predicts surgical risk for patients with liver disease

Ann Surg. 1983 Dec;198(6):701-4. doi: 10.1097/00000658-198312000-00006.

Abstract

To determine whether the [14C] aminopyrine breath test (ABT) predicts surgical risk in patients with liver disease, it was obtained prior to various surgeries in 38 patients with known or suspected liver disease. A modified Child's classification was also determined. Six of the seven operative deaths (three Child's A, two B, two C) had ABTs less than 2.3%, while 30 of 31 survivors (24 Child's A, seven B) had ABTs greater than 2.3% (p less than 0.000018). Seven of the 16 patients with normal ABTs had biopsy-proven cirrhosis and had postoperative courses indistinguishable from the remainder of the group. We conclude that surgery in patients with ABTs less than 2.3% is associated with extremely high mortality. In addition, cirrhotics with normal ABTs tolerate elective surgery well.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aminopyrine*
  • Breath Tests*
  • Female
  • Humans
  • Liver Diseases / mortality
  • Liver Diseases / physiopathology
  • Liver Diseases / surgery*
  • Liver Diseases, Alcoholic / mortality
  • Liver Diseases, Alcoholic / physiopathology
  • Liver Diseases, Alcoholic / surgery
  • Liver Function Tests / methods
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prognosis
  • Risk

Substances

  • Aminopyrine